A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
A “patent interference” proceeding will determine who controls foundational patents on gene editing.
The disorder known as trisomy 21 is untreatable. Or is it? Some families think an antidepressant could help.
The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
A radical new approach to generating human organs is to grow them inside pigs or sheep.
Better concussion diagnostics will give scientists and physicians a more detailed understanding of brain injury.
During 2015, the combination of potent biotechnologies solved problems and created new ones.
We need therapies to help those with Down syndrome reach their potential.
Efforts to breed two extinct species of Galapagos tortoise back into existence set a new bar for the use of genetics in conservation.
Diana Bianchi championed tests that find Down syndrome early in pregnancy. Now can she find a way to treat it?